Tamoxifen-regulated adenoviral E1A chimeras for the control of tumor selective oncolytic adenovirus replication in vitro and in vivo.
about
Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy.Gene transfer for congestive heart failure: update 2013.Cellular targeting for cochlear gene therapy.Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban.
P2860
Tamoxifen-regulated adenoviral E1A chimeras for the control of tumor selective oncolytic adenovirus replication in vitro and in vivo.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Tamoxifen-regulated adenoviral ...... lication in vitro and in vivo.
@en
Tamoxifen-regulated adenoviral ...... lication in vitro and in vivo.
@nl
type
label
Tamoxifen-regulated adenoviral ...... lication in vitro and in vivo.
@en
Tamoxifen-regulated adenoviral ...... lication in vitro and in vivo.
@nl
prefLabel
Tamoxifen-regulated adenoviral ...... lication in vitro and in vivo.
@en
Tamoxifen-regulated adenoviral ...... lication in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
Tamoxifen-regulated adenoviral ...... lication in vitro and in vivo.
@en
P2093
A Hurtado Picó
P2860
P2888
P304
P356
10.1038/SJ.GT.3302604
P577
2006-01-01T00:00:00Z
P5875
P6179
1046706601